Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand.
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Bone remodelling and bone loss are controlled by a balance between the tumour necrosis factor family molecule osteoprotegerin ligand (OPGL) and its decoy receptor osteoprotegerin (OPG). In addition, OPGL regulates lymph node organogenesis, lymphocyte development and interactions between T cells and dendritic cells in the immune system. The OPGL receptor, RANK, is expressed on chondrocytes, osteoclast precursors and mature osteoclasts. OPGL expression in T cells is induced by antigen receptor engagement, which suggests that activated T cells may influence bone metabolism through OPGL and RANK. Here we report that activated T cells can directly trigger osteoclastogenesis through OPGL. Systemic activation of T cells in vivo leads to an OPGL-mediated increase in osteoclastogenesis and bone loss. In a T-cell-dependent model of rat adjuvant arthritis characterized by severe joint inflammation, bone and cartilage destruction and crippling, blocking of OPGL through osteoprotegerin treatment at the onset of disease prevents bone and cartilage destruction but not inflammation. These results show that both systemic and local T-cell activation can lead to OPGL production and subsequent bone loss, and they provide a novel paradigm for T cells as regulators of bone physiology.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“RANKL is produced by numerous cell types including cells of the osteoblast lineage (46,47) and activated T cells (42,48,49).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [49]
In the citing paper
“T Cells express both soluble and membrane-bound forms of RANKL (49,50), and both forms are implicated in focal bone erosions associated with inflammatory arthritis (26,49).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [49]
In the citing paper
“Within the developed immune system, RANKL is expressed by T cells (42), RANK is expressed by dendritic cells (49), and OPG is expressed by B lymphocytes and dendritic cells (4,70).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [49]
In the citing paper
“However, RANK and RANKL knockout mice had normal Peyer's patches and intact splenic architecture (49,62), indicating that the development of lymph nodes and secondary lymphoid organs can be differentially regulated.”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [49]
In the citing paper
“RANKL inhibition via recombinant OPG treatment also results in marked suppression of bone erosions and osteoclasts in several rodent models, including adjuvant arthritis (26,49,177,232,233), collagen-induced arthritis (26,181,233), and TNF-mediated arthritis (136, 234).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [49]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Self-citationOsteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
Self-citationOPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351 · cited 1×
“We show that: (1) p66 is serine phosphorylated upon treatment with hydrogen peroxide (H2O2) or irradiation with ultraviolet light; (2) ablation of p66 enhances cellular resistance to apoptosis induced by H2O2 or ultraviolet light; (3) a serinephosphorylation defective mutant of p66 cannot restore the normal stress res…”
BackgroundSelf-citationRAG-1-deficient mice have no mature B and T lymphocytes
Mombaerts, P., Iacomini, J., Johnson, R. S., Herrup, K., Tonegawa, S., & Papaioannou, V. E. (1992) · Cell · doi:10.1016/0092-8674(92)90030-g · Cited by 2,931
Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4
Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesser, H., & Mak, T. W. (1995) · Science · doi:10.1126/science.270.5238.985 · Cited by 2,766
Self-citationROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS
Feldmann, M., Brennan, F. M., & Maini, R. N. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.397 · Cited by 2,514
A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.
Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., & Galibert, L. (1997) · Nature · doi:10.1038/36593 · Cited by 2,290
Kotake, S., Udagawa, N., Takahashi, N., Matsuzaki, K., Itoh, K., Ishiyama, S., Saito, S., Inoue, K., Kamatani, N., Gillespie, M. T., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5703 · Cited by 1,696
Hsu, H., Lacey, D. L., Dunstan, C. R., Solovyev, I., Colombero, A., Timms, E., Tan, H.-L., Elliott, G., Kelley, M. J., Sarosi, I., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3540 · Cited by 1,636
Self-citationWong, B. R., Rho, J., Arron, J., Robinson, E., Orlinick, J., Chao, M., Kalachikov, S., Cayani, E., Bartlett, F. S., Frankel, W. N., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.25190 · Cited by 1,042
Cited by
Items 601–700 of 1,007
mTORC1 impedes osteoclast differentiation via calcineurin and NFATc1
Huynh, H., & Wan, Y. (2018) · Communications Biology · doi:10.1038/s42003-018-0028-4 · Cited by 75
Recognizing and treating secondary osteoporosis
Walker-Bone, K. E. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.93 · Cited by 78
T-Cells Mediate an Inhibitory Effect of Interleukin-4 on Osteoclastogenesis
Mirosavljevic, D., Quinn, J. M. W., Elliott, J., Horwood, N. J., Martin, T. J., & Gillespie, M. T. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.6.984 · Cited by 77
TNF-α mediates the stimulation of sclerostin expression in an estrogen-deficient condition
Kim, B., Bae, S. J., Lee, S.-Y., Lee, Y., Baek, J., Park, S., Lee, S. H., Koh, J., & Kim, G. S. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.06.100 · Cited by 76
Botelho, C., Brooks, R. A., Spence, G. M., McFarlane, I., Lopes, M. A., Best, S. M., Santos, J. D., Rushton, N., & Bonfield, W. (2006) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.30726 · Cited by 78
Designing proteins for bone targeting
Gittens, S. A., BANSAL, G., Zernicke, R. F., & Uludağ, H. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.12.015 · Cited by 77
Pietschmann, P., Grisar, J. C., Thien, R., Willheim, M., Kerschan‐Schindl, K., Preisinger, E., & Peterlik, M. (2001) · Experimental Gerontology · doi:10.1016/s0531-5565(01)00125-5 · Cited by 69
Immunotherapy for rheumatoid arthritis
Taylor, P. C., Williams, R. O., & Maini, R. N. (2001) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00269-7 · Cited by 69
Totsuka, T., Kanai, T., Nemoto, Y., Tomita, T., Okamoto, R., Tsuchiya, K., Nakamura, T., Sakamoto, N., Akiba, H., Okumura, K., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0711823 · Cited by 67
“(26) initially reported that the blockade of this pathway by using soluble recombinant osteoprotegerin (OPG) protein at the onset of disease prevented bone and cartilage destruction, but interestingly not inflammation in a T cell-dependent model of rat adjuvant arthritis.”
BackgroundRANKL Upregulation Associated With Periodontitis and Porphyromonas gingivalis
Wara‐aswapati, N., Surarit, R., Chayasadom, A., Boch, J. A., & Pitiphat, W. (2007) · Journal of Periodontology · doi:10.1902/jop.2007.060398 · Cited by 94
Fluoxetine treatment increases trabecular bone formation in mice
Battaglino, R. A., Vokes, M. S., Schulze‐Späte, U., Sharma, A., Graves, D. T., Kohler, T., Müller, R., Yoganathan, S., & Stashenko, P. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21131 · Cited by 68
“Bone loss induced by inflammation results from increased numbers of osteoclasts [Kong et al., 1999].”
BackgroundSkoumal, M., Kolarz, G., Haberhauer, G., Woloszczuk, W., Hawa, G., & Klingler, A. (2005) · Rheumatology International · doi:10.1007/s00296-004-0579-1 · Cited by 66
“From this membranebound form, a soluble homotrimeric molecule (sRANKL) can be produced by activated T-lymphocytes, or can be generated from the cell-bound form by the metalloprotease disintegrin TNF alpha convertase (TACE) [14, 15].”
BackgroundRANKL and RANK in sex hormone-induced breast cancer and breast cancer metastasis
Schramek, D., Sigl, V., & Penninger, J. M. (2011) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2011.02.007 · Cited by 79
Self-citationA review of denosumab for the treatment of osteoporosis
Miyazaki, T., Tokimura, F., & Tanaka, S. (2014) · Patient Preference and Adherence · doi:10.2147/ppa.s46192 · Cited by 68
Koufany, M., Moulin, D., Bianchi, A., Muresan, M., Sebillaud, S., Netter, P., Weryha, G., & Jouzeau, J.-Y. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2354 · Cited by 66
Postmenopausal osteoporosis, T cells, and immune dysfunction
Teitelbaum, S. L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407335101 · Cited by 68
Huang, W., O'Keefe, R. J., & Schwarz, E. M. (2002) · Arthritis Res Ther · doi:10.1186/ar612 · Cited by 67
Interleukin-18 Is a Novel Mitogen of Osteogenic and Chondrogenic Cells
Cornish, J., Gillespie, M. T., Callon, K. E., Horwood, N. J., Moseley, J. M., & Reid, I. R. (2003) · Endocrinology · doi:10.1210/en.2002-220936 · Cited by 75
Haynes, D. R. (2004) · Inflammation Research · doi:10.1007/s00011-004-1303-z · Cited by 69
Kaur, K., Hardy, R., Ahasan, M. M., Eijken, M., van Leeuwen, J. P., Filer, A., Thomas, A. M., Raza, K., Buckley, C. D., Stewart, P. M., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.107466 · Cited by 66
Induction of IL-10-producing CD4 + T-cells in Chronic Periodontitis
Kobayashi, R., Kôno, T., Bolerjack, B. A., Fukuyama, Y., Gilbert, R. S., Fujihashi, K., Ruby, J. D., Kataoka, K., Wada, M., Yamamoto, M., et al. (2011) · Journal of Dental Research · doi:10.1177/0022034510397838 · Cited by 78
“…and molecular aspects of GMCs isolated from mice exhibiting significant inflammation inducing osteoclast differentiation (Horwood et al., 1999; Kong et al., 1999), previous studies have shown that activated CD4+ T-cell subsets and their cytokines can have pro- or anti-osteoclastogenic effects…”
BackgroundExpression of cathepsin-K in gingival crevicular fluid of patients with periodontitis
Mogi, M., & Otogoto, J.-I. (2007) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2007.01.006 · Cited by 66
Foxp3+ Regulatory T Cells in Bone and Hematopoietic Homeostasis
Fischer, L., Herkner, C., Kitte, R., Dohnke, S., Riewaldt, J., Kretschmer, K., & Garbe, A. I. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00578 · Cited by 68
HIV-1 infection and antiretroviral therapies: risk factors for osteoporosis and bone fracture
Ofotokun, I., & Weitzmann, M. N. (2010) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32833f48d6 · Cited by 70
Implant wear induces inflammation, but not osteoclastic bone resorption, in RANK–/– mice
Ren, W., Wu, B., Peng, X., Hua, J., Hao, H., & Wooley, P. H. (2006) · Journal of Orthopaedic Research® · doi:10.1002/jor.20190 · Cited by 69
“In addition, the failure of RANK / mice to mount a significant osteoclastic response in the presence of experimental inflammatory arthritis further supports the concept that RANK plays a gate-keeping role in controlling osteoclastogenesis,(10) and mice lacking RANKL have defects in osteoclastogenesis that leads to sev…”
BackgroundLange, F., Bajtner, E., Rintisch, C., Nandakumar, K. S., Sack, U., & Holmdahl, R. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.026120 · Cited by 65
Park, J.-S., Park, M.-K., Oh, H.-J., Woo, Y.-J., Lim, M.-A., Lee, J.-H., Ju, J. H., Jung, Y. O., Lee, Z. H., Park, S.-H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051377 · Cited by 65
“Increased osteoclast activity can cause severe damage to the bone, leading to the progressive destruction of arthritic joints [2].”
BackgroundLessons from animal models of arthritis over the past decade
Berg, W. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2803 · Cited by 67
“Cytokines like TNF, IL-1 and IL-17 cause bone erosion through up-regulation of receptor activator of NF-kappaB ligand (RANKL), formerly called osteoprotegerin ligand [80].”
Byrne, F. R., Morony, S., Warmington, K., Geng, Z., Brown, H. L., Flores, S. A., Fiorino, M., Yin, S. L., Hill, D., Porkess, V, et al. (2005) · Gut · doi:10.1136/gut.2003.035113 · Cited by 65
Self-citationNanki, T., & Lipsky, P. E. (2000) · Arthritis Research & Therapy · doi:10.1186/ar120 · Cited by 69
Estrogen receptors in breast and bone: from virtue of remodeling to vileness of metastasis
Bado, I., Gugala, Z., Fuqua, S. A. W., & Zhang, X. (2017) · Oncogene · doi:10.1038/onc.2017.94 · Cited by 71
Occlusal trauma accelerates attachment loss at the onset of experimental periodontitis in rats
Nakatsu, S., Yoshinaga, Y., Kuramoto, A., Nagano, F., Ichimura, I., Oshino, K., Yoshimura, A., Yano, Y., & Hara, Y. (2013) · Journal of Periodontal Research · doi:10.1111/jre.12109 · Cited by 67
The intestinal microbiome and skeletal fitness: Connecting bugs and bones
Charles, J. F., Ermann, J., & Aliprantis, A. O. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.03.019 · Cited by 64
Osteoclasts in arthritis and Th17 cell development
Okamoto, K., & Takayanagi, H. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.11.010 · Cited by 73
Ohno, H., Uemura, Y., Murooka, H., Takanashi, H., Tokieda, T., Ohzeki, Y., Kubo, K., & Serizawa, I. (2008) · European Journal of Immunology · doi:10.1002/eji.200737199 · Cited by 64
Transplantation of SHED Prevents Bone Loss in the Early Phase of Ovariectomy-induced Osteoporosis
Liu, Y., Wang, L., Liu, S., Liu, D., Chen, C., Xu, X., Chen, X., & Shi, S. (2014) · Journal of Dental Research · doi:10.1177/0022034514552675 · Cited by 69
“It has been reported that activated T-cells play a key role in the regulation of osteoclast formation through the production of IFN-γ and TNF-α, augmenting RANKL-induced osteoclastogenesis (Kong et al., 1999; Takayanagi et al., 2000; Weitzmann et al., 2001).”
BackgroundNakajima, K., Kho, D. H., Yanagawa, T., Harazono, Y., Hogan, V. A., Chen, W., Ali‐Fehmi, R., Mehra, R., & Raz, A. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1793 · Cited by 67
The impact of the intestinal microbiome on bone health
Zhang, J., Lu, Y., Wang, Y., Ren, X., & Han, J. (2018) · Intractable & Rare Diseases Research · doi:10.5582/irdr.2018.01055 · Cited by 72
Stolina, M., Dwyer, D., Ominsky, M. S., Corbin, T., Van, G., Bolon, B., Sarosi, I., McCabe, J., Zack, D. J., & Kostenuik, P. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.11.7497 · Cited by 63
Self-citationThe role of Th/Treg immune cells in osteoarthritis
Wen, Z. H., Qiu, L., Ye, Z., Tan, X., Xu, X., Lu, M., & Kuang, G. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1393418 · Cited by 71
“In a T cell-dependent mouse arthritis model, the blocking of RANKL with OPG can prevent the destruction of bone and cartilage, but cannot inhibit in fl ammation (38).”
BackgroundBone-Immune Cell Crosstalk: Bone Diseases
Mori, G., D’Amelio, P., Faccio, R., & Brunetti, G. (2015) · Journal of Immunology Research · doi:10.1155/2015/108451 · Cited by 69
Hofbauer, L. C., Schoppet, M., Christ, M., Teichmann, J., & Lange, U. (2006) · Rheumatology · doi:10.1093/rheumatology/kel108 · Cited by 63
de Vries, T. J., el Bakkali, I., Kamradt, T., Schett, G. A., Jansen, I. D. C., & D’Amelio, P. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00505 · Cited by 70
“Together, these data indicate a crucial role for T-cells in osteoclast formation in RA, in line with earlier studies that demonstrated the activating role of T-cells in osteoclast formation (8, 49) which initiated osteoimmunology research.”
BackgroundResultKlerck, B. D., Carpentier, I., Lories, R. J. U., Habraken, Y., Piette, J. G., Carmeliet, G., Beyaert, R., Billiau, A., & Matthys, P. (2004) · Arthritis Research & Therapy · doi:10.1186/ar1167 · Cited by 64
Ono, K., Kaneko, H., Choudhary, S., Pilbeam, C. C., Lorenzo, J., Akatsu, T., Kugai, N., & Raisz, L. G. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.041027 · Cited by 63
Wang, Y., Li, Y., Bo, L., Zhou, E., Chen, Y., Naranmandakh, S., Xie, W., Ru, Q., Chen, L., Zhu, Z., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2263207 · Cited by 73
“…and TNF-α-producing T cells produces a large number of pro-inflammatory cytokines (IL-17 and TNF-α), receptor activator of NF-κB ligand (RANKL), 107 and decreases the secretion of RANKL antagonists (RANKL induces osteoclast function while IL-17 reduces bone formation; TNF-α enhances the…”
BackgroundLi, Y.-J., Kukita, A., Teramachi, J., Nagata, K., Wu, Z., Akamine, A., & Kukita, T. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.111 · Cited by 62
Martínez-Calatrava, M. J., Prieto-Potín, I., Roman-Blas, J. A., Tardio, L., Largo, R., & Herrero-Beaumont, G. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3884 · Cited by 62
Rath‐Wolfson, L., Bar‐Yehuda, S., Madi, L., Ochaion, A., Cohen, S., Zabutti, A., & Fishman, P. (2006) · PubMed · Cited by 61
Kamijo, S., Nakajima, A., Ikeda, K., Aoki, K., Ohya, K., Akiba, H., Yagita∥, H., & Okumura, K. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.06.098 · Cited by 63
Alves, C. H., Farrell, E., Vis, M., Colin, E. M., & Lubberts, E. (2015) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8522-7 · Cited by 70
Dickkopf1: An immunomodulatory ligand and Wnt antagonist in pathological inflammation
Chae, W., & Bothwell, A. L. M. (2019) · Differentiation · doi:10.1016/j.diff.2019.05.003 · Cited by 61
“, osteopetrotic) due to the lack of osteoclastogenesis (Kong et al., 1999).”
BackgroundSerum Osteoprotegerin Is Increased in Crohnʼs Disease: a Population-Based Case Control Study
Bernstein, C. N., Sargent, M. J., & Leslie, W. D. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000164015.60795.ca · Cited by 67
Interaction of Fas Ligand and Fas Expressed on Osteoclast Precursors Increases Osteoclastogenesis
Park, H., Jung, Y., Park, O.-J., Lee, Y. J., Choi, J., & Choi, Y. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.11.7193 · Cited by 62
“Because activated T cells express RANKL, T cell-mediated bone destruction was shown in ctla4 / mice (10).”
BackgroundTitanji, K. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01851 · Cited by 64
Veerappan, S. G., O’Morain, C. A., Daly, J. S., & Ryan, B. M. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04667.x · Cited by 66
Osteoclastogenesis and arthritis
Maruotti, N., Grano, M., Colucci, S. C., Donofrıo, F., & Cantatore, F. P. (2010) · Clinical and Experimental Medicine · doi:10.1007/s10238-010-0117-2 · Cited by 71
“On the one hand, there are many evidences that T-cells may induce osteoclastogenesis via RANKL expression [80, 81].”
BackgroundDelpino, M. V., Barrionuevo, P., Macedo, G. C., Oliveira, S. C., Genaro, S. D., Scian, R., Miraglia, M. C., Fossati, C. A., Baldi, P. C., & Giambartolomei, G. H. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.04111185 · Cited by 61
Djaafar, S., Pierroz, D. D., Chicheportiche, R., Zheng, X. X., Ferrari, S. L., & Ferrari‐Lacraz, S. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27645 · Cited by 61
Analysis of the kinetics of osteoclastogenesis in arthritic rats
Schett, G. A., Stolina, M., Bolon, B. N., Middleton, S. C., Adlam, M., Brown, H., Zhu, L., Feige, U., & Zack, D. J. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21343 · Cited by 69
Self-citationMitogen‐activated protein (MAP) kinases mediate PMMA‐induction of osteoclasts
Abbas, S., Clohisy, J. C. F., & Abu‐Amer, Y. (2003) · Journal of Orthopaedic Research® · doi:10.1016/s0736-0266(03)00081-0 · Cited by 67
Oral mucosal dendritic cells and periodontitis: many sides of the same coin with new twists
Cutler, C. W., & Teng, Y.-T. A. (2007) · Periodontology 2000 · doi:10.1111/j.1600-0757.2007.00222.x · Cited by 73
Yoneda, T., Ishimaru, N., Arakaki, R., Kobayashi, M., Izawa, T., Moriyama, K., & Hayashi, Y. (2004) · Endocrinology · doi:10.1210/en.2003-1536 · Cited by 60
Mei, H., Wu, Z., & Nakanishi, H. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2011.54 · Cited by 68
Apalset, E. M., Gjesdal, C. G., Ueland, P. M., Midttun, Ø., Ulvik, A., Eide, G. E., Meyer, K., & Tell, G. S. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12288 · Cited by 62
Wu, Z., Mei, H., Kukita, T., Nakanishi, Y., & Nakanishi, H. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0803609 · Cited by 66
Septic arthritis: immunopathogenesis, experimental models and therapy
Colavite, P. M., & Sartori, A. (2014) · The Journal of venomous animals and toxins including tropical diseases · doi:10.1186/1678-9199-20-19 · Cited by 64
Firouzi, D., Youssef, A., Amer, M., Srouji, R. M., Amleh, A., Foucher, D. A., & Bougherara, H. (2014) · Journal of the mechanical behavior of biomedical materials/Journal of mechanical behavior of biomedical materials · doi:10.1016/j.jmbbm.2014.01.001 · Cited by 61
Immune regulation of bone loss by T h17 cells in oestrogen‐deficient osteoporosis
Zhao, R. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12158 · Cited by 66
Gene expression in giant-celltumors
Skubitz, K. M., Cheng, E. Y., Clohisy, D. R., Thompson, R. C., & Skubitz, A. P. N. (2004) · Journal of Laboratory and Clinical Medicine · doi:10.1016/j.lab.2004.06.005 · Cited by 61
T‐cell phenotype as a risk factor for periodontal disease
Houri‐Haddad, Y., Wilensky, A., & Shapira, L. (2007) · Periodontology 2000 · doi:10.1111/j.1600-0757.2007.00227.x · Cited by 60
Autocrine signaling is a key regulatory element during osteoclastogenesis
Kopesky, P. W., Tiedemann, K., Alkekhia, D., Zechner, C., Millard, B. L., Schoeberl, B., & Komarova, S. V. (2014) · Biology Open · doi:10.1242/bio.20148128 · Cited by 66
Rifas, L., & Arackal, S. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10872 · Cited by 64
Role of the RANK/RANKL pathway in breast cancer
Kiesel, L., & Kohl, A. (2016) · Maturitas · doi:10.1016/j.maturitas.2016.01.001 · Cited by 64
Breuil, V., Schmid‐Antomarchi, H., Schmid‐Alliana, A., Rezzonico, R., Euller‐Ziegler, L., & Rossi, B. (2003) · The FASEB Journal · doi:10.1096/fj.02-1188fje · Cited by 253
Inflammation, a prototype for organogenesis of the lymphopoietic/hematopoietic system
Nishikawa, S.-I., Hashi, H., Honda, K., Fraser, S. T., & Yoshida, H. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00097-2 · Cited by 63
Plasma cells promote osteoclastogenesis and periarticular bone loss in autoimmune arthritis
Komatsu, N., Win, S. J., Yan, M., Huynh, N. C., Sawa, S., Tsukasaki, M., Terashima, A., Pluemsakunthai, W., Kollias, G., Nakashima, T., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci143060 · Cited by 69
“Therefore, we provide the first convincing evidence to our knowledge that it is the synovial fibroblast RANKL rather than the RANKL derived from B or T cells that is responsible for joint erosion, using mice on the arthritogenic DBA1/J background (7, 21, 22, 28, 29).”
BackgroundNason, R., Jung, J. Y., & Chole, R. A. (2009) · Journal of the Association for Research in Otolaryngology · doi:10.1007/s10162-008-0153-8 · Cited by 62
Li, X., Kim, K., Cho, M., Ju, J., Kang, C., Oh, H.-J., Min, J., Lee, S., Park, S., & Kim, H. (2009) · Immunology Letters · doi:10.1016/j.imlet.2009.10.012 · Cited by 61
Gazzola, L., Bellistrì, G. M., Tincati, C., Ierardi, V., Savoldi, A., Sole, A. D., Tagliabue, L., Monforte, A. D., & Marchetti, G. C. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-51 · Cited by 57
Regulation of osteoclast protease expression by RANKL
Wittrant, Y., Théoleyre, S., Couillaud, S., Dunstan, C. R., Heymann, D., & Rédiní, F. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.09.084 · Cited by 62
Schett, G. A., Middleton, S. C., Bolon, B. N., Stolina, M., Brown, H., Zhu, L., Pretorius, J., Zack, D. J., Kostenuik, P. J., & Feige, U. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21021 · Cited by 62
Self-citationBaker, P. J., Howe, L., Garneau, J., & Roopenian, D. C. (2002) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2002.tb00601.x · Cited by 70
Immunohistochemical expression of RANK, GRα and CTR in central giant cell granuloma of the jaws
Tobón‐Arroyave, S. I., Franco-González, L. M., Isaza‐Guzmán, D. M., Flórez‐Moreno, G. A., BRAVOVASQUEZ, T., CASTANEDAPELAEZ, D., & Vieco‐Durán, B. (2005) · Oral Oncology · doi:10.1016/j.oraloncology.2004.11.006 · Cited by 70
Tumor necrosis factor-alpha: Alternative role as an inhibitor of osteoclast formation in vitro
Balga, R., Wetterwald, A., Portenier, J., Dolder, S., Mueller, C., & Hofstetter, W. (2006) · Bone · doi:10.1016/j.bone.2006.02.056 · Cited by 60
Maffia, P., Brewer, J. M., Gracie, J. A., Ianaro, A., Leung, B. P. L., Mitchell, P. J., Smith, K. M., McInnes, I. B., & Garside, P. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.1.151 · Cited by 65
Udagawa, N. (2003) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-003-0439-1 · Cited by 65
Biomimetic immunomodulation by crosstalk with nanoparticulate regulatory T cells
Li, S., Wang, L., Gu, Y., Lin, L., Zhang, M., Jin, M., Mao, C., Zhou, J. M., Zhang, W., Huang, X., et al. (2021) · Matter · doi:10.1016/j.matt.2021.08.015 · Cited by 61
RANK ligand inhibition with denosumab for the management of osteoporosis
Lewiecki, E. M. (2006) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.6.10.1041 · Cited by 63
Biochemical markers in oncology. Part I: Molecular basis. Part II: Clinical uses
Voorzanger‐Rousselot, N., & Garnero, P. (2007) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2007.01.008 · Cited by 63
Coupling of Bone Resorption and Formation during Bone Remodeling
Martin, T. J., & Rodan, G. A. (2001) · Elsevier eBooks · doi:10.1016/b978-012470862-4/50013-1 · Cited by 65
The Role of Intestinal Flora in the Regulation of Bone Homeostasis
Li, C., Pi, G., & Li, F. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.579323 · Cited by 65
Osteoclasts and osteoarthritis: Novel intervention targets and therapeutic potentials during aging
Wang, H., Yuan, T., Wang, Y., Liu, C., Li, D., Li, Z., & Sun, S. (2024) · Aging Cell · doi:10.1111/acel.14092 · Cited by 69
“…such as bone marrow adipogenic lineage precursors (MALPs), CXC chemokine ligand 12 (CXCL12)- abundant reticular (CAR) cells, lymphocytes, synovial fibroblasts, and periodontal ligament cells (Kong et al., 1999; Sato et al., 2006; Tsukasaki & Takayanagi, 2019; Veis & O'Brien, 2023; Yu et al., 2021).”
BackgroundOsteoclastic bone resorption induced by innate immune responses: Bone resorption and TLR signals
Koide, M., Kinugawa, S., Takahashi, N., & Udagawa, N. (2010) · Periodontology 2000 · doi:10.1111/j.1600-0757.2010.00355.x · Cited by 63
The Cellular Dynamics of Bone Remodeling: A Mathematical Model
Ryser, M. D., Komarova, S. V., & Nigam, N. (2010) · SIAM Journal on Applied Mathematics · doi:10.1137/090746094 · Cited by 60
“Among the multiple messengers involved, RANKL and OPG have been shown to play critical roles in both physiological bone remodeling and in the development of diseases [25, 5, 21].”
BackgroundRANKL/RANK – From bone physiology to breast cancer
Sigl, V., & Penninger, J. M. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.01.002 · Cited by 63
Self-citationAmeloblastoma induces osteoclastogenesis: a possible role of ameloblastoma in expanding in the bone
Sandra, F., Hendarmin, L. A., Kukita, T., Nakao, Y., Nakamura, N., & Nakamura, S. (2005) · Oral Oncology · doi:10.1016/j.oraloncology.2005.02.008 · Cited by 58
Regulation of bone destruction in rheumatoid arthritis through RANKL-RANK pathways
Tanaka, S. (2013) · World Journal of Orthopedics · doi:10.5312/wjo.v4.i1.1 · Cited by 60
Cancer and diet: How are they related?
Sung, B., Prasad, S., Yadav, V. R., Lavasanifar, A., & Aggarwal, B. B. (2011) · Free Radical Research · doi:10.3109/10715762.2011.582869 · Cited by 64
Luvizuto, E. R., Queiroz, T. P., Dias, S. M. D., Okamoto, T., Dornelles, R. C. M., Júnior, I. R. G., & Okamoto, R. (2009) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2009.11.001 · Cited by 77
Metadata
- Authors
- Kong, Y.-Y., Feige, U., Sarosi, I., Bolon, B., Tafuri, A., Morony, S., Capparelli, C., Li, J., Elliott, R., McCabe, S., Wong, T., Campagnuolo, G., Moran, E., Bogoch, E. R., Van, G., Nguyen, L. T., Ohashi, P. S., Lacey, D. L., Fish, E., Boyle, W. J., & Penninger, J. M.
- Affiliations
- Amgen (Canada) (CA)
- Amgen (United States) (US)
- St. Michael's Hospital (CA)
- University of Toronto (CA)
- ORCID
- Venue
- Nature
- Published
- 1999-11
- Volume
- 402
- Issue
- 6759
- Pages
- 304-309
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1677043489
- Cited by
- 1,856
- References
- 24
- Citations by year
- 2026: 17 · 2025: 33 · 2024: 36 · 2023: 33 · 2022: 25 · 2021: 36 · 2020: 47 · 2019: 43 · 2018: 38 · 2017: 59 · 2016: 64 · 2015: 82 · 2014: 80 · 2013: 85 · 2012: 77
- FWCI
- 26.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Cystic Fibrosis Foundation
- U.S. Public Health Service
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Health Sciences › Medicine › Rheumatology › Osteomyelitis and Bone Disorders Research
- Keywords
- osteoprotegerin ligand, osteoprotegerin, RANK, activated T cells, adjuvant-induced arthritis, bone loss, osteoclastogenesis, joint destruction, cartilage destruction, T cell activation, bone remodeling, osteoclasts
- MeSH terms
- Animals, Arthritis, Experimental, Bone and Bones, Bone Resorption, Carrier Proteins, Cartilage, Cells, Cultured, Glycoproteins, Humans, Lymphocyte Activation, Membrane Glycoproteins, Mice, Inbred C57BL, Rats, Inbred Lew, T-Lymphocytes, Receptors, Tumor Necrosis Factor, Receptors, Cytoplasmic and Nuclear, Coculture Techniques, Mice, Rats, Osteoprotegerin, RANK Ligand, Receptor Activator of Nuclear Factor-kappa B
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.